The North American Neuromodulation Society (NANS) is celebrating its 30th anniversary in 2024 and is onc...
Nevro* (NVRO) announced it acquired VYRSA Technologies*, a privately held company focused on the minimal...
Medtronic Neurovascular President Dan Volz discusses expanding patient access to neurovascular therapies...
SNIS President J Mocco, MD, discusses emerging technologies and new frontiers in neurointervention in an...
SmartTRAK constantly monitors the worldwide MedTech industry, sifting through the noise to present to ou...
Neuromodulation companies are keeping their fingers crossed that the positive growth in Q123 is a sign t...
SmartTRAK’s survey of interventional pain physicians reveals valuable insights into current and future t...
Rebecca Wilkins, DVP R&D Neuromodulation for Abbott, discusses the Eterna SCS, strategies for penetr...
While the macro environment is improving, some neuromodulation companies and segments navigated choppy w...
Saluda Medical President and CEO Jim Schuermann discusses the Company, the Evoke System and changing the...